Latest news, press releases, and SEC filings for Aclaris Therapeutics Inc (ACRS) https://caymanjournal.com/stock/ACRS en-us Copyright 2026, Cayman Journal editorial@caymanjournal.com (Editorial Team) webmaster@caymanjournal.com (Web Master) Mon, 27 Apr 2026 20:27:15 GMT 60 https://caymanjournal.com/logo.png https://caymanjournal.com 144 144 # 🧾 What This Document Is This filing is the **Annual Report to Shareholders (ARS)** for Aclaris Therapeutics for the year ending December 31, 2025. Think of it as a company's official, comprehensive yearly report card sent directly to its owners (the shareholders). It's designed to be a detailed https://caymanjournal.com/stock/ACRS/sec-filing/0001104659-26-047264 https://caymanjournal.com/stock/ACRS/sec-filing/0001104659-26-047264 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing # 🧾 What This Document Is This is a **DEF 14A**, also known as a **Proxy Statement**. Think of it as an official invitation and information packet for Aclaris Therapeutics' upcoming shareholder meeting. Its main job is to give shareholders the details they need to vote on important company decision https://caymanjournal.com/stock/ACRS/sec-filing/0001104659-26-047262 https://caymanjournal.com/stock/ACRS/sec-filing/0001104659-26-047262 Thu, 23 Apr 2026 00:00:00 GMT SEC Filing